Impairment of health after overcoming the acute phase of COVID-19 is being observed more and more frequently. Here different symptoms of neurological and/or cardiological origin have been reported. With symptoms, which are very similar to the ones reported but are not caused by SARS-CoV-2, the occurrence of functionally active autoantibodies (fAABs) targeting G-protein coupled receptors…
Journal of Translational Autoimmunity Template
Write in a clean editor, then format for Journal of Translational Autoimmunity in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Journal of Translational Autoimmunity format
Journal of Translational Autoimmunity is a peer-reviewed journal published by Elsevier, covering Systemic Lupus Erythematosus Research, Diabetes and associated disorders, T-cell and B-cell Immunology.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Journal of Translational Autoimmunity 12 (2023) 45–58.
Formats any DOI in Journal of Translational Autoimmunity style. No sign-up. |
| Publishes research in | Systemic Lupus Erythematosus Research Diabetes and associated disorders T-cell and B-cell Immunology Liver Diseases and Immunity Rheumatoid Arthritis Research and Therapies |
| ISSN | 2589-9090 |
| Citation impact (2-yr) | 3.23 |
| h-index | 37 |
| i10-index | 147 |
| Total citations | 5,536 |
| Article processing charge | $2,250 |
| Open access | Yes |
| Top institutions publishing here | Inserm |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Journal of Translational Autoimmunity per year
Citation impact of Journal of Translational Autoimmunity by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Journal of Translational Autoimmunity
Homology between human and viral proteins is an established factor in viral- or vaccine-induced autoimmunity. Failure of SARS and MERS vaccines in animal trials involved pathogenesis consistent with an immunological priming that could involve autoimmunity in lung tissues due to previous exposure to the SARS and MERS spike protein. Exposure pathogenesis to SARS-CoV-2 in COVID-19…
Chronic nonbacterial osteomyelitis (CNO) is an inflammatory bone disorder that most frequently affects children and adolescents. Chronic recurrent multifocal osteomyelitis (CRMO) is a severe form of CNO, usually characterized by symmetrical inflammatory bone lesions and its waxing and waning character. Sometimes severe and chronic pain can significantly affect the quality of life and psychosocial development…
Polymyositis (PM) and dermatomyositis (DM) are different disease subtypes of idiopathic inflammatory myopathies (IIMs). The main clinical features of PM and DM include progressive symmetric, predominantly proximal muscle weakness. Laboratory findings include elevated creatine kinase (CK), autoantibodies in serum, and inflammatory infiltrates in muscle biopsy. Dermatomyositis can also involve a characteristic skin rash. Both polymyositis…
Autoimmune diseases are characterized by a failure of tolerance to own body components resulting in tissue damage. Regulatory T cells are gatekeepers of tolerance. This review focusses on the function and pathophysiology of regulatory T cells in the context of autoimmune diseases including rheumatoid and juvenile idiopathic arthritis as well as systemic lupus erythematosus with…